Posaconazole Prophylaxis in Experimental Azole-Resistant Invasive Pulmonary Aspergillosis
Open Access
- 1 March 2015
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (3) , 1487-1494
Abstract
We investigated the efficacy of posaconazole prophylaxis in preventing invasive aspergillosis due to azole-resistant Aspergillus fumigatus isolates. Using a neutropenic murine model of pulmonary infection, posaconazole prophylaxis was evaluated using three isogenic clinical isolates, with posaconazole MICs of 0.063 mg/liter (wild type), 0.5 mg/liter (F219I mutation), and 16 mg/liter. A fourth isolate harboring TR34/L98H (MIC of 0.5 mg/liter) was also tested. Posaconazole prophylaxis was effective in A. fumigatus with posaconazole MICs of ≤0.5 mg/liter, where 100% survival was reached. However, breakthrough infection was observed in mice infected with the isolate for which the posaconazole MIC was >16 mg/liter.Keywords
This publication has 54 references indexed in Scilit:
- First Reported Case of Azole-Resistant Aspergillus fumigatus Due to the TR/L98H Mutation in GermanyAntimicrobial Agents and Chemotherapy, 2012
- Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the LiteratureAntimicrobial Agents and Chemotherapy, 2012
- Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of ProphylaxisAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal TherapyThe Journal of Infectious Diseases, 2011
- Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated AspergillosisAntimicrobial Agents and Chemotherapy, 2010
- Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant RecipientsAntimicrobial Agents and Chemotherapy, 2010
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A GeneAntimicrobial Agents and Chemotherapy, 2010
- Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical TriazolesApplied and Environmental Microbiology, 2009
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2009
- Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining FluidAntimicrobial Agents and Chemotherapy, 2008